Program for Alleviating Relationship Trauma and Stress for Intimate Partner Violence - Randomized… (NCT07747766) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Program for Alleviating Relationship Trauma and Stress for Intimate Partner Violence - Randomized Control Trial
United States48 participantsStarted 2026-08-01
Plain-language summary
This research study investigates the feasibility of a randomized control trial of a group-based treatment program for reducing stress, trauma, substance use, and use of violence among individuals who were court-mandated to attend a program after committing an act(s) of domestic violence. The study is in a 2-arm design with an intervention group and a control group.
Who can participate
Age range
18 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Must be male-identifying or prefer to be in a male-identifying group;
* Must be a resident of Washington state;
* Must be court-referred to a treatment program for using violence with an intimate partner;
* Have sufficient English fluency and literacy skills to understand the consent process, procedures and questionnaires and have the ability to provide written informed consent;
* Have access to the internet and an electronic device with adequate data capacity; to complete questionnaires online and attend online video conference groups;
* Must be available and willing to attend at least 17 out of 20 scheduled online group sessions; and
* Must be available and willing to complete the online computerized assessments, and phone interviews.
Exclusion Criteria:
* Insufficiently stable housing or internet connection to be able to join at least 17 group sessions;
* Current participation in another experimental research study;
* Expected medical hospitalization in the next six months from study enrollment period;
* Current or expected physical incarceration (excluding house arrest or other forms of electronic monitoring) in the next six months from study enrollment period;
* Inpatient hospitalization for mental health, substance use, suicide attempt or self-harm within past three months;
* Inability to participate safely in the study intervention and without disrupting the group (in the opinion of principal investigator OR meeting any of the following criteri…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
H1.1 - Intervention Feasibility
Timeframe: From enrollment to the end of treatment at 20 weeks